Zoan Biomed awarded ISO 13485:2016 certification for the Design, Development and Manufacture of Bone Graft Substitutes

team outside with view cert

December 2021,
Zoan Biomed was awarded it’s ISO 13485:2016 certification – the international standard for quality management systems in the medical device industry. This is a fundamental step ahead of market approval and registration of our Zoan G03 product in the US and Europe.

This is the outcome of a multi year effort that has taken our innovative, sustainable and natural solution and translated that into an internationally recognised platform that is ready for manufacturing and human use.

James Martin, Production Director and Flora Joyce, Scientific Officer & QA Lead led the initiation, development, and execution of the Quality Management System supported by the day-to-day expertise of Michael O’Donnell and Rose Mongan.

It gives the company a substantial foundation now to meet the requirements of customers, ensure compliance with regulation and drive excellence in the day-to-day operating practices. Most importantly it is a key step in delivering on our key principle of patient safety

Zoan Biomed has completed its most recent 12 month GLP pre-clinical trial which delivered further exciting results on our materials ability to heal bone and provide outstanding structural stability, while being biocompatible and bioresorbable.

Latest News

Natural Resource Conservation – Zoan Biobank

Recent extreme weather events in Europe and news of coral bleaching and death of some of the most resilient corals in the Florida Keys are shining a spotlight on the need for government, politicians, business and individuals to think and act sustainably.  Zoan has a unique living library of 30+ corals in a state-of-the-art facility at…

Visiting Cellink

Thank you to the Cellink team for hosting us in their highly impressive facility in Gothenberg.

We are making excellent progress towards our development of 3D bioprinted tissue model containing sustainably grown coral skeletal particles.

Zoan and partners at TERMIS 2023

Zoan, Cellink and University of Galway collaboration on 3D printable coral-containing bioinks to present results at TERMIS, Manchester, 28-31st March 2023: Biocompatibility of 3D bioprinted tissue model prototypes containing sustainably grown coral skeletal particles for orthopedic applicationsE. Pernevik et. al. Zoan and partners at CELLINK and University of Galway will be presenting the early results from our coral bioink…

Our Sustainability Model

As a Med Tech company that aims to improve people’s health, we recognise the need to preserve a healthy environment. The link between human and environmental health is well established: the WHO states that one in four premature deaths is related to environmental issues caused by humans and the World Bank acknowledges that sustainable management…

Contact Us

To find out more about Zoan BioMed get in touch